Tau-174 CSF Biomarker: TDP-43 vs Tau in FTLD Patients
Breakthrough AcTau174 Biomarker Revolutionizes FTLD-TDP Diagnosis and Tracking Medical researchers have uncovered a critical diagnostic breakthrough that could fundamentally change how clinicians identify and manage frontotemporal lobar degeneration (FTLD). A newly identified cerebrospinal fluid biomarker, known as AcTau174, has demonstrated a remarkable ability to pinpoint FTLD-TDP, a specific and devastating form of the disease. This … Read more